Organon (OGN) Market Capitalization (2021 - 2026)

Organon has reported Market Capitalization for 6 years, with the latest figure at $3.6 billion in Q2 2026.

• On a quarterly basis, Market Capitalization rose 41.3% year-over-year to $3.6 billion in Q2 2026; TTM through Jun 2026 was $3.6 billion, a 41.3% increase from a year earlier, with the FY2025 full-year figure at $1.9 billion, down 51.47% from the prior year.
• Market Capitalization was $3.6 billion for Q2 2026 at Organon, up from $1.6 billion in the prior quarter.
• The five-year high for Market Capitalization was $8.9 billion in Q1 2022, with the low at $1.6 billion in Q1 2026.
• Average Market Capitalization over 5 years is $4.7 billion, with a median of $4.6 billion recorded in 2023.
• The largest YoY upside for Market Capitalization was 41.3% in 2026 against a maximum downside of 59.04% in 2026.
• Over 5 years, Market Capitalization stood at $7.1 billion in 2022, then tumbled by 48.12% to $3.7 billion in 2023, then increased by 4.35% to $3.8 billion in 2024, then plunged by 51.47% to $1.9 billion in 2025, then soared by 90.51% to $3.6 billion in 2026.
• The last three Market Capitalization figures came in at $3.6 billion (Q2 2026), $1.6 billion (Q1 2026), and $1.9 billion (Q4 2025), per Business Quant data.